Loading...
Please wait, while we are loading the content...
Similar Documents
Treatment of Helicobacter pylori: an overview
| Content Provider | Scilit |
|---|---|
| Author | Axon, A. T. R. |
| Copyright Year | 2000 |
| Description | Journal: Alimentary Pharmacology & Therapeutics Helicobacter pylori is recognized to be a serious pathogen, but there is still controversy as to who should be treated. There is consensus for treatment of Helicobacter‐positive peptic ulcer and B‐cell lymphoma. Lymphocytic gastritis and giant‐fold gastritis (Ménétrièr's disease) may also respond to treatment. Patients with func‐tional dyspepsia have a 20% placebo response with a 5–10% ‘eradication’ response, results not dissimilar from empirical treatment with a proton pump inhibitor. A ‘test and treat’ policy for patients with uninvesti‐gated dyspepsia remains controversial. Some have suggested that eradication may increase the risk of GERD, or predispose to adenocarcinoma at the gastro‐oesophageal junction. However, PPI treatment without Helicobacter eradication induces greater inflammation in the gastric corpus, the phenotype associated with non‐cardia gastric cancer. A minority believe that Helicobacter should be eradicated in all individuals. When choosing treatment it is logical to start with a combination of antibiotics that, in the event of failure, will allow a second combination to be used without overlap. |
| Ending Page | 6 |
| Starting Page | 1 |
| ISSN | 2573508X |
| e-ISSN | 13652036 |
| DOI | 10.1046/j.1365-2036.2000.00394.x |
| Journal | Alimentary Pharmacology & Therapeutics |
| Volume Number | 14 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2000-10-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Alimentary Pharmacology & Therapeutics Gastroenterology and Hepatology Helicobacter Pylori |
| Content Type | Text |
| Resource Type | Article |